Jacque J. Sokolov, M.D. is chairman and chief executive officer of SSB, a diversified US based healthcare company with four strategic business units: 1) SSB Solutions (Management Consulting/Advisory Services - 150+ markets); 2) SSB Investments (Captive Healthcare Investment Fund); 3) SSB Financial Services/Healthcare Community Development Group-HCDG (New Markets Tax Credits, Opportunity Zone Development, etc.); and 4) SSB Governmental Services (Veteran’s Accountable Care Organization/Group-VACO/VACG, etc.). Following his formal training as an academic cardiologist, Dr. Sokolov has had the opportunity to serve as board director, corporate officer and advisor in multiple healthcare sectors including: Health Plans/Large Employers; Hospitals/Hospital Systems; Physician Practice Management Organizations/Group Practices; Clinically Integrated Organizations (CIOs/ACOs); Pharmaceutical Companies; Device Companies; Biotechnology Companies; and Private Equity/Venture Entities. He started his career as Vice President for Healthcare and Chief Medical Officer for Southern California Edison Corporation (NYSE: EIX). Dr. Sokolov currently serves or has served in multiple board capacities for Public Companies including Hospira (NYSE: HSP), MedCath (NASDAQ: MDTH), and PhyAmerica (NYSE: ERDR); Private Companies including GlobalMed, Zoonie(SMG), MyHealthDirect, NeuLife Neurological Services (NeuLife), Calviri, AKOS, the Trill Project and SSB wholly owned companies; and Non Profit Organizations including Phoenix Children’s Hospital, The Health Futures Council at ASU, The Executive Committee of the Board of Councilors for the USC School of Pharmacy, The National Health Foundation, the American College of Medical Quality, the National Fund for Medical Education, and the National Business Group on Health and the White House Health Project.
Dr. Sokolov received his BA and MD Degrees from the University of Southern California. He completed his internal medicine residency at the Mayo Graduate School of Medicine and his fellowship in cardiovascular diseases from the University of Texas-Southwestern Medical School. He previously held and currently holds academic appointments and advisory board responsibilities in the Schools of Medicine, Business and Public Health at Harvard, the Massachusetts Institute of Technology, the University of Pennsylvania, the University of California, Los Angeles, and the University of Southern California.